Study evaluates COVID-19 vaccination with GI disorders

2021-10-12

Outcomes for patients who had confirmed COVID-19 and gastrointestinal symptoms were similar to patients in a control group, but those with GI symptoms often had nausea up to a month later, Giovanni Marasco, MD, PhD, of the University of Bologna in Italy, told UEG Week Virtual. A second study, published in JAMA Internal Medicine and led by Binu John, MD, MPH, of the University of Miami Miller School of Medicine, found mRNA COVID-19 vaccines led to a slower and lower immune response in adult patients with cirrhosis.

Full story:

ACG SmartBrief

Providing the latest, need-to-know medical headlines and news that affect gastroenterologists

Designed specifically for digestive disorder specialists, ACG SmartBrief is a FREE, twice-weekly e-mail newsletter. By providing the latest, need-to-know medical headlines and news that affect gastroenterologists, ACG SmartBrief saves you time and keeps you smart.